Biomarkers in solid organ transplantation.
Recipients of solid organs such as the kidney and heart are treated with standard immunosuppressive regimens, and personalized medicine has not yet reached the clinic for this patient population. Biomarkers potentially will allow treatment regimens to be adjusted, according to the needs of the individual patient. Biomarkers may reflect the degree of immunosuppression of the immune system, or they may reflect early damage to the transplanted organ.
['van Gelder|Teun|T|']
D015415:Biomarkers D054357:Chemokine CXCL10 D006084:Graft Rejection D006801:Humans D007166:Immunosuppressive Agents D016030:Kidney Transplantation D035683:MicroRNAs D016377:Organ Transplantation D011379:Prognosis
biomarkers transplantation immunosuppression rejection